AVE 0.00% 0.2¢ avecho biotechnology limited

cellulite fattens coffers, page-46

  1. 5,270 Posts.
    lightbulb Created with Sketch. 244
    minime-

    Let's keep discussions of CZD on the CZD forum.

    However two points need addressing here since they have been raised.

    First, Dr. Greenwood is not involved in the AOD9604 program with Calzada/Metabolic. To the best of my knowledge his focus in entirely on the treatment of burns/wounds using PolyNovo's biodegradable polymers. You may have meant to refer to Professor Ng.

    Second, recent royalty income to CZD from Bodyshaper haven't been released, but it was widely understood a few months ago, based on publicly released data, that CZD was disappointed with the pace of royalties and there was a bit of mutual finger pointing as a result. I have seen or learned nothing to indicate that there has been any significant increase in the pace of royalty payments to CZD. I hope that this minimal phraseology won't result in this post being moderated out of existence.

    Unless AOD9604 can be incorporated into the formulation of Bodyshaper sold outside Australia, I don't see much chance of this situation changing significantly.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.